Metabolite

KNApSAcK Entry

id C00035832
Name Ginkgolide J
CAS RN 107438-79-9
Standard InChI InChI=1S/C20H24O10/c1-6-12(23)27-7-5-17-11-8(21)9(16(2,3)4)18(17)10(22)13(24)29-15(18)30-20(17,14(25)28-11)19(6,7)26/h6-11,15,21-22,26H,5H2,1-4H3
Standard InChI (Main Layer) InChI=1S/C20H24O10/c1-6-12(23)27-7-5-17-11-8(21)9(16(2,3)4)18(17)10(22)13(24)29-15(18)30-20(17,14(25)28-11)19(6,7)26/h6-11,15,21-22,26H,5H2,1-4H3

Cluster

Phytochemical cluster No. 44
KCF-S cluster No. 2137

Link

ChEMBL

By standard InChI
By standard InChI Main Layer CHEMBL2112172

KEGG

By LinkDB C07604

CTD

By CAS RN C075228

Species

Summary

Plant class

class name count
Spermatophyta 1

Family

family name count
Ginkgoaceae 1

List (1)

* NCBI
KNApSAcK organism *ID *family *plant class *kingdom
Ginkgo biloba 3311 Ginkgoaceae Spermatophyta Viridiplantae

Human Protein / Gene in interaction

1 ChEMBL Protein in interactions

accession description class description compound assay ID (# of activities) # of diseases
(OMIM / KEGG)
P25105 Platelet-activating factor receptor PAF receptor CHEMBL2112172 CHEMBL760444 (1) CHEMBL760445 (1)
0 / 0

CTD interaction (3)

compound gene gene name gene description interaction interaction type form reference
pmid
C075228 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin co-treated with ginkgolide A co-treated with ginkgolide B co-treated with ginkgolide C co-treated with ginkgolide J co-treated with bilobalide] affects the activity of CYP1A1 protein affects activity
/ affects cotreatment
protein 21329749
C075228 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin co-treated with ginkgolide A co-treated with ginkgolide B co-treated with ginkgolide C co-treated with ginkgolide J co-treated with bilobalide] inhibits the reaction [Benzo(a)pyrene results in increased activity of CYP1A1 protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 21329749
C075228 1543 CYP1A1
AHH
AHRR
CP11
CYP1
P1-450
P450-C
P450DX
cytochrome P450, family 1, subfamily A, polypeptide 1 (EC:1.14.14.1) [Quercetin co-treated with kaempferol co-treated with 3-methylquercetin co-treated with ginkgolide A co-treated with ginkgolide B co-treated with ginkgolide C co-treated with ginkgolide J co-treated with bilobalide] inhibits the reaction [Tetrachlorodibenzodioxin results in increased activity of CYP1A1 protein] affects cotreatment
/ decreases reaction
/ increases activity
protein 21329749